Literature DB >> 14602058

Genetic and pathogenetic insights into inflammatory bowel disease.

Francesco Pallone1, Giovanna Del Vecchio Blanco, Piero Vavassori, Ivan Monteleone, Daniele Fina, Giovanni Monteleone.   

Abstract

Crohn's disease (CD) and ulcerative colitis (UC) are chronic inflammatory disorders of the gastrointestinal tract that share clinical and pathologic characteristics. The most credible hypothesis is that CD and UC result from an inappropriate and exaggerated mucosal immune response to normal constituents of the mucosal microflora that is in part genetically determined. However, there is reason to believe that the main pathologic processes in these two diseases are distinct. For example, the CARD15/NOD2 gene has been identified as a susceptibility gene for CD but not for UC. Moreover, the study of patients and mouse models of inflammatory bowel disease has clearly shown that, in CD, the tissue-damaging inflammatory reaction is driven by interleukin-12-activated Th1 cells, whereas a humoral response predominates in UC.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14602058     DOI: 10.1007/s11894-003-0038-2

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  48 in total

1.  Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB.

Authors:  Y Ogura; N Inohara; A Benito; F F Chen; S Yamaoka; G Nunez
Journal:  J Biol Chem       Date:  2000-11-21       Impact factor: 5.157

Review 2.  The genetics of inflammatory bowel disease.

Authors:  Denise K Bonen; Judy H Cho
Journal:  Gastroenterology       Date:  2003-02       Impact factor: 22.682

Review 3.  Mechanisms of TGF-beta signaling from cell membrane to the nucleus.

Authors:  Yigong Shi; Joan Massagué
Journal:  Cell       Date:  2003-06-13       Impact factor: 41.582

4.  Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease.

Authors:  J Satsangi; K I Welsh; M Bunce; C Julier; J M Farrant; J I Bell; D P Jewell
Journal:  Lancet       Date:  1996-05-04       Impact factor: 79.321

5.  Mapping of a susceptibility locus for Crohn's disease on chromosome 16.

Authors:  J P Hugot; P Laurent-Puig; C Gower-Rousseau; J M Olson; J C Lee; L Beaugerie; I Naom; J L Dupas; A Van Gossum; M Orholm; C Bonaiti-Pellie; J Weissenbach; C G Mathew; J E Lennard-Jones; A Cortot; J F Colombel; G Thomas
Journal:  Nature       Date:  1996-02-29       Impact factor: 49.962

6.  CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease.

Authors:  Suzanne Lesage; Habib Zouali; Jean-Pierre Cézard; Jean-Frédéric Colombel; Jacques Belaiche; Sven Almer; Curt Tysk; Colm O'Morain; Miquel Gassull; Vibeke Binder; Yigael Finkel; Robert Modigliani; Corinne Gower-Rousseau; Jeanne Macry; Françoise Merlin; Mathias Chamaillard; Anne-Sophie Jannot; Gilles Thomas; Jean-Pierre Hugot
Journal:  Am J Hum Genet       Date:  2002-03-01       Impact factor: 11.025

7.  Lack of common NOD2 variants in Japanese patients with Crohn's disease.

Authors:  Nagamu Inoue; Kazuo Tamura; Yoshitaka Kinouchi; Yoshihiro Fukuda; Seiichi Takahashi; Yasunori Ogura; Naohiro Inohara; Gabriel Núñez; Yusuke Kishi; Yuji Koike; Tooru Shimosegawa; Takashi Shimoyama; Toshifumi Hibi
Journal:  Gastroenterology       Date:  2002-07       Impact factor: 22.682

8.  Molecularly defined HLA-DR2 alleles in ulcerative colitis and an antineutrophil cytoplasmic antibody-positive subgroup.

Authors:  R H Duerr; D A Neigut
Journal:  Gastroenterology       Date:  1995-02       Impact factor: 22.682

9.  Haplotype structure and association to Crohn's disease of CARD15 mutations in two ethnically divergent populations.

Authors:  Peter J P Croucher; Silvia Mascheretti; Jochen Hampe; Klaus Huse; Henning Frenzel; Monika Stoll; Tim Lu; Susanna Nikolaus; Suk-Kyun Yang; Michael Krawczak; Won Ho Kim; Stefan Schreiber
Journal:  Eur J Hum Genet       Date:  2003-01       Impact factor: 4.246

10.  Expression of transforming growth factors alpha and beta in colonic mucosa in inflammatory bowel disease.

Authors:  M W Babyatsky; G Rossiter; D K Podolsky
Journal:  Gastroenterology       Date:  1996-04       Impact factor: 22.682

View more
  5 in total

Review 1.  Diagnosis of inflammatory bowel disease: Potential role of molecular biometrics.

Authors:  Amosy E M'Koma
Journal:  World J Gastrointest Surg       Date:  2014-11-27

2.  Proteomic profiling of mucosal and submucosal colonic tissues yields protein signatures that differentiate the inflammatory colitides.

Authors:  Amosy E M'Koma; Erin H Seeley; Mary K Washington; David A Schwartz; Roberta L Muldoon; Alan J Herline; Paul E Wise; Richard M Caprioli
Journal:  Inflamm Bowel Dis       Date:  2010-08-30       Impact factor: 5.325

3.  On the genetic involvement of apoptosis-related genes in Crohn's disease as revealed by an extended association screen using 245 markers: no evidence for new predisposing factors.

Authors:  Sonja E N Wagenleiter; Peter Jagiello; Denis A Akkad; Larissa Arning; Thomas Griga; Wolfram Klein; Jörg T Epplen
Journal:  J Negat Results Biomed       Date:  2005-11-30

4.  Immunohistochemical analysis of retinoblastoma and β-catenin as an assistant tool in the differential diagnosis between Crohn's disease and ulcerative colitis.

Authors:  Rossana Colla Soletti; Nathassya Accioly Lins Vidal Rodrigues; Deborah Biasoli; Ronir Raggio Luiz; Heitor Siffert Pereira de Souza; Helena Lobo Borges
Journal:  PLoS One       Date:  2013-08-14       Impact factor: 3.240

5.  Association of the T allele of an intronic single nucleotide polymorphism in the colony stimulating factor 1 receptor with Crohn's disease: a case-control study.

Authors:  Adriana Zapata-Velandia; San-San Ng; Rebecca F Brennan; Neal R Simonsen; Mariella Gastanaduy; Jovanny Zabaleta; Jennifer J Lentz; Randall D Craver; Hernan Correa; Alberto Delgado; Angela L Pitts; Jane R Himel; John N Udall; Eberhard Schmidt-Sommerfeld; Raynorda F Brown; Grace B Athas; Bronya B Keats; Elizabeth E Mannick
Journal:  J Immune Based Ther Vaccines       Date:  2004-05-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.